cyclohexylaminoglutethimide has been researched along with Acute Myelogenous Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ai, H; Chen, L; Hao, Q; Mi, R; Song, Y; Wang, P; Wei, X; Yin, Q; Yuan, F | 1 |
| Chen, L; Wei, XD; Yin, QS | 1 |
2 other study(ies) available for cyclohexylaminoglutethimide and Acute Myelogenous Leukemia
| Article | Year |
|---|---|
[Efficacy analysis of CHAG priming regimen as induction therapy for newly diagnosed acute myelogenous leukemia].
Topics: Glutethimide; Humans; Leukemia, Myeloid, Acute; Neoadjuvant Therapy | 2015 |
[Comparative evaluation of CHAG and CAG priming regimen for treatment of refractory and relapsed acute myeloid leukemia].
Topics: Aclarubicin; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Female; Glutethimide; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Treatment Outcome; Young Adult | 2012 |